Thompson Investment Management’s AstraZeneca AZN Stock Holding History

Thompson Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.4K	Buy	324 +11	+4%	+$2.07K	0.01%	255
2026 Q1	$61.7K	Sell	313 -64	-17%	-$12.3K	0.01%	249
2025 Q4	$69.2K	Sell	377 -22	-6%	-$3.86K	0.01%	238
2025 Q3	$61.2K	Sell	399 -262	-40%	-$39.7K	0.01%	259
2025 Q2	$92.3K	Hold	661	–	–	0.01%	226
2025 Q1	$97.1K	Buy	661 +11	+2%	+$1.59K	0.01%	218
2024 Q4	$85.1K	Sell	650 -379	-37%	-$53.1K	0.01%	230
2024 Q3	$160K	Hold	1,029	–	–	0.02%	183
2024 Q2	$161K	Hold	1,029	–	–	0.02%	181
2024 Q1	$139K	Buy	1,029 +10	+1%	+$1.32K	0.02%	183
2023 Q4	$137K	Hold	1,019	–	–	0.02%	189
2023 Q3	$138K	Sell	1,019 -19	-2%	-$2.6K	0.02%	183
2023 Q2	$149K	Sell	1,038 -22	-2%	-$3.24K	0.02%	187
2023 Q1	$147K	Buy	+1,060	New	+$143K	0.02%	186
2022 Q3	–	Sell	-4,192	Closed	-$554K	–	185
2022 Q2	$554K	Sell	4,192 -683	-14%	-$89.6K	0.1%	125
2022 Q1	$647K	Hold	4,875	–	–	0.1%	128
2021 Q4	$568K	Sell	4,875 -350	-7%	-$41.2K	0.08%	146
2021 Q3	$628K	Buy	+5,225	New	+$608K	0.09%	137

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thompson Investment Management's AZN Position: Q2 2026 in Review

Thompson Investment Management increased its AstraZeneca (AZN) stake by 3.5% in Q2 2026, buying an estimated $2.07K and bringing the position to 324 shares worth $61.4K. The position accounts for 0.01% of the portfolio, ranked #255.

Thompson Investment Management first reported a position in AZN in Q3 2021 and has held it in 18 quarters since. The position peaked at $647K in Q1 2022. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Thompson Investment Management held 324 shares of AstraZeneca worth $61.4K as of Q2 2026.
Thompson Investment Management bought 11 AstraZeneca shares in Q2 2026, an estimated $2.07K.
AstraZeneca made up 0.01% of Thompson Investment Management's portfolio in Q2 2026, its #255 holding.
Thompson Investment Management first reported a position in AstraZeneca in Q3 2021 and has held it in 18 quarters since.
Thompson Investment Management's AstraZeneca position peaked at $647K in Q1 2022.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.